Montreal, Canada

Enobia Pharma Inc.


USPTO Granted Patents = 7

% Expired Patents = 42.9


Forward Citations = 174

Loading Chart...
Loading Chart...

11 inventors (with patents filed for the assignee):

goldMedal Guy Boileau (5 out of 10 patents)

silverMedal Philippe Crine (4 out of 11 patents)

bronzeMedal Isabelle Lemire (4 out of 7 patents)

4.  Thomas P Loisel (2 out of 7 patents)

5.  Denis Gravel (2 out of 15 patents)

6.  Christian Lanctot (2 out of 3 patents)

7.  Pierre Moffatt (2 out of 2 patents)

8.  Elaref S Ratemi (2 out of 2 patents)

9.  Mostafa Hatam (2 out of 2 patents)

10.  Gethin Thomas (1 out of 1 patent)

11.  Patrick Salois (1 out of 2 patents)

12.  Pierre Leonard (2 patents)

13.  Robert Heft (1 patent)

14.  Hal Landy (0 patent)

15.  Christian Lanctot (0 patent)


7 patents:

Company Overview
Enobia Pharma Inc. is a biotechnology company specializing in developing and commercializing innovative therapies for rare genetic bone disorders. With a focus on improving the lives of patients through groundbreaking research and development, Enobia is dedicated to addressing unmet medical needs in the field of rare diseases.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

7 Patents

#151 in Montreal

#2,100 in Canada

Montreal, CA
Montreal, Canada
Forward Citations = 174

11 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Enobia Pharma Inc.. Retrieved from https://idiyas.com/company/enobia-pharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…